Françoise Brun‐Vézinet

14.8k citations

207 papers · 9.8k indexed · 2 hit papers · h-index 52

Virology top 0.02%
- HIV Research and Treatment 167
Infectious Diseases top 0.05%
- HIV/AIDS drug development and treatment 147
- HIV/AIDS Research and Interventions 107
Hepatology top 1%
- Hepatitis C virus research 10
Epidemiology top 1%
- Pneumocystis jirovecii pneumonia detection and treatment 15
- Cytomegalovirus and herpesvirus research 11
Immunology top 2%
- T-cell and Retrovirus Studies 17
Emergency Medicine
- HIV-related health complications and treatments 18

Co-authors: Daniel R. Kuritzkes Bonaventura Clotet Victoria A. Johnson Florence Damond Diane Descamps Douglas D. Richman François Simon Ibtissam Loussert-Ajaka
Cited by: Virology Infectious Diseases Hepatology
Journals: Science (2 papers)New England Journal of Medicine (2 papers)The Lancet (5 papers)
Partner nations: France United States United Kingdom

In The Last Decade

Françoise Brun‐Vézinet

204 papers receiving 9.4k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Françoise Brun‐Vézinet

Since Specialization

Citations

This map shows the geographic impact of Françoise Brun‐Vézinet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Françoise Brun‐Vézinet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Françoise Brun‐Vézinet more than expected).

Fields of papers citing papers by Françoise Brun‐Vézinet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Françoise Brun‐Vézinet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Françoise Brun‐Vézinet. The network helps show where Françoise Brun‐Vézinet may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Françoise Brun‐Vézinet, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Françoise Brun‐Vézinet Line = papers co-authored together Françoise Brun‐Vézinet links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Limited HIV-2 reservoirs in central-memory CD4 T-cells associated to CXCR6 co-receptor expression in attenuated HIV-2 infection PLoS Pathogens ·Assia Samri,Charlotte Charpentier,Mariama Sadjo Diallo,Mélanie Bertine,Sophie Even,Véronique Morin,Anne Oudin,Christophe Parizot,Gilles Collin,Anne Hosmalin,Rémi Cheynier,Rodolphe Thiébaut,Sophie Matheron,Fidéline Collin,Rima Zoorob,Françoise Brun‐Vézinet,Brigitte Autran,(unknown)	2019	6
2	Preservation of Lymphopoietic Potential and Virus Suppressive Capacity by CD8+ T Cells in HIV-2–Infected Controllers The Journal of Immunology ·(unknown),Mathieu Angin,Glenn Wong,Laura Papagno,Pierre Versmisse,Annie David,Charles Bayard,Bénédicte Charmeteau-De Muylder,Amel Besseghir,Rodolphe Thiébaut,Faroudy Boufassa,Gianfranco Pancino,Delphine Sauce,Olivier Lambotte,Françoise Brun‐Vézinet,Sophie Matheron,Sarah Rowland‐Jones,Rémi Cheynier,Asier Sáez‐Cirión,Victor Appay	2016	14
3	Isolation of a New Retrovirus in a Patient at Risk for Acquired Immunodeficiency Syndrome Antibiotics and chemotherapy/Antibiotica et chemotherapia ·J C Chermann,F. Barr�-Sinoussi,C. Dauguet,Françoise Brun‐Vézinet,C. Rouzioux,Willy Rozenbaum,Luc Montagnier	2015	2
4	In-vitro phenotypic susceptibility of HIV-1 ’non-B’ integrase inhibitors naive clinical isolates to dolutegravir and raltegravir AIDS ·Charlotte Charpentier,Mélanie Bertine,Benoît Visseaux,Juliette Leleu,Lucile Larrouy,Gilles Peytavin,Thomas Mourez,Gilles Collin,Françoise Brun‐Vézinet,Jean‐Christophe Plantier,Diane Descamps	2013	6
5	Prevalence of subtype-related polymorphisms associated with in vitro resistance to attachment inhibitor BMS-626529 in HIV-1 'non-B'-infected patients Journal of Antimicrobial Chemotherapy ·C. Charpentier,Lucile Larrouy,Benoît Visseaux,Roland Landman,M. Levittas,Alexandre Storto,Florence Damond,Yazdan Yazdanpanah,P. Yéni,Françoise Brun‐Vézinet,Diane Descamps	2012	20
6	Long-term nonprogressors and elite controllers in the ANRS CO5 HIV-2 cohort AIDS ·Rodolphe Thiébaut,Sophie Matheron,Audrey Taïeb,Françoise Brun‐Vézinet,Geneviève Chêne,Brigitte Autran	2011	25
7	Update of the Drug Resistance Mutations in HIV-1: December 2010 PubMed ·Victoria A. Johnson,Françoise Brun‐Vézinet,Bonaventura Clotet,Huldrych F. Günthard,Daniel R. Kuritzkes,Deenan Pillay,Douglas D. Richman,(unknown)	2010	71
8	Predictive Value of HIV‐1 Genotypic Resistance Test Interpretation Algorithms The Journal of Infectious Diseases ·Soo‐Yon Rhee,W. Jeffrey Fessel,Tommy F. Liu,Natalia Marlowe,Charles M. Rowland,Richard A. Rode,Anne–Mieke Vandamme,Kristel Van Laethem,Françoise Brun‐Vézinet,Vincent Cálvez,Jonathan Taylor,Leo B. Hurley,Michael A. Horberg,Robert W. Shafer	2009	37
9	Molecular testing of multiple HIV-1 transmissions in a criminal case AIDS ·Philippe Lemey,Sonia Van Dooren,Kristel Van Laethem,Yoeri Schrooten,Inge Derdelinckx,Patrick Goubau,Françoise Brun‐Vézinet,Dolorès Vaira,Anne–Mieke Vandamme	2005	32
10	HIV Type 1 Diversity in Northeastern Romania in 2000-2001 Based on Phylogenetic Analysis of pol Sequences from Patients Failing Antiretroviral Therapy AIDS Research and Human Retroviruses ·Cristian Apetrei,Diane Descamps,Gilles Collin,David L. Robertson,Ivona Pandrea,Petru Groza,Liviu Prisecariu,Irina Teodorescu,Vasile Luca,Françoise Brun‐Vézinet	2003	10
11	Predictors of virological rebound in HIV-1-infected patients initiating a protease inhibitor-containing regimen AIDS ·Vincent Le Moing,Geneviève Chêne,Patrizia Carrieri,Ahmadou Alioum,Françoise Brun‐Vézinet,Lionel Piroth,Jill P. Cassuto,Jean‐Paul Moatti,François Raffi,Catherine Leport	2002	141
12	Phylogenetic Analysis of 49 Newly Derived HIV-1 Group O Strains: High Viral Diversity but No Group M-like Subtype Structure Virology ·Pierre Roques,David L. Robertson,Sandrine Souquière,Florence Damond,Ahidjo Ayouba,Isabelle Farfara,Christel Depienne,Eric Nerrienet,Dominique Dormont,Françoise Brun‐Vézinet,François Simon,Philippe Mauclère	2002	51
13	Prevalence of resistance mutations in antiretroviral-naive chronically HIV-infected patients in 1998: a French nationwide study AIDS ·Diane Descamps,Vincent Cálvez,Jacques Izopet,Claudine Buffet‐Janvresse,Anne Schmuck,Philippe Colson,Annick Ruffault,Anne Maillard,Bernard Masquelier,Jacqueline Cottalorda,M Harzic,Françoise Brun‐Vézinet,Dominique Costagliola	2001	30
14	HIV-1 diversity in France, 1996–1998 AIDS ·Élisabeth Couturier,Florence Damond,Pierre Roques,Hervé Fleury,Françis Barin,Jean‐Baptiste Brunet,Françoise Brun‐Vézinet,François Simon	2000	87
15	HIV Type 1 Diversity and the Reliability of the Heteroduplex Mobility Assay AIDS Research and Human Retroviruses ·Ibtissam Loussert-Ajaka,Elisabeth Menu,Cristian Apetrei,Martine Peeters,Florence Damond,Philippe Mauclère,Josef Eberle,Cécile Brengues,Sentob Saragosti,Françoise Barré‐Sinoussi,Françoise Brun‐Vézinet,François Simon	1998	17
16	Cellular and plasma viral load in patients infected with HIV-2 AIDS ·François Simon,Sophie Matheron,Catherine Tamalet,Ibtissam Loussert-Ajaka,Sergio Bartczak,J. M. Pepin,Catherine Dhiver,Emmanuelle Gamba,Carole Elbim,lean A. Gastaut,Adrien G. Saimot,Françoise Brun‐Vézinet	1993	140
17	Algorithmes du diagnostic sérologique des infections par VIH-1 et VIH-2 Cahiers d'études et de recherches francophones / Santé ·François Simon,Jean-Michel Pépin,Didier Furet,Sergio Bartczak,Emmanuelle Gamba,Sophie Matheron,Françoise Brun‐Vézinet	1992	1
18	[Human immunodeficiency virus (HIV) infection in Mali]. PubMed ·É. Pichard,A. Guindo,G Grossetête,Youssouf Fofana,Maiga Yi,B Koumaré,Sékou F. Traorè,M Maiga,Françoise Brun‐Vézinet,M. Rosenheim	1989	5
19	Cholangitis in the acquired immunodeficiency syndrome: report of two cases and review of the literature. Gut ·Dominique Roulot,Dominique Valla,Françoise Brun‐Vézinet,M.A. Rey,F Clavel,C Degott,J Guillan,J Verduron,B Rueff,J P Benhamou	1987	24
20	Neuropathie périphérique en relation avec l'infection par le rétrovirus LAV/HTLV III. Etude clinique, anatomique et immunologique. Cinq observations. La Presse Médicale ·C. Leport,Marie‐Pierre Chaunu,J Sicre,Françoise Brun‐Vézinet,J J Hauw,J. L. Vildé	1987	8

About Françoise Brun‐Vézinet

Françoise Brun‐Vézinet is a scholar working on Virology, Infectious Diseases and Emergency Medicine, having authored 207 papers that have together received 9.8k indexed citations. Recurring topics across this work include HIV Research and Treatment (167 papers), HIV/AIDS drug development and treatment (147 papers), HIV/AIDS Research and Interventions (107 papers), HIV-related health complications and treatments (18 papers), T-cell and Retrovirus Studies (17 papers), Pneumocystis jirovecii pneumonia detection and treatment (15 papers), Cytomegalovirus and herpesvirus research (11 papers) and Hepatitis C virus research (10 papers). The work is most often cited by research in Virology (8.2k citations), Infectious Diseases (7.7k citations) and Hepatology (638 citations). Françoise Brun‐Vézinet has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Daniel R. Kuritzkes, Bonaventura Clotet, Victoria A. Johnson, Florence Damond, Diane Descamps, Douglas D. Richman, François Simon, Ibtissam Loussert-Ajaka, Jonathan Schapiro and Sophie Matheron. Their work appears in journals such as Science, New England Journal of Medicine and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact